PlainRecalls
FDA Drug Moderate Class II Terminated

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

Reported: October 2, 2019 Initiated: September 17, 2019 #D-1878-2019

Product Description

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

Reason for Recall

cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

Details

Recalling Firm
Akorn, Inc.
Units Affected
10,543 tubes
Distribution
Nationwide within the United States and Puerto Rico
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30. Recalled by Akorn, Inc.. Units affected: 10,543 tubes.
Why was this product recalled?
cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 2, 2019. Severity: Moderate. Recall number: D-1878-2019.